About: Arthur W. Nienhuis

Facets (new session)
Description
Metadata
Settings
- Rule:
- Inverse Functional Properties:
- "Same As":

About: Arthur W. Nienhuis Goto Sponge NotDistinct Permalink

An Entity of Type : yago:Whole100003553, within Data Space : dbpedia.demo.openlinksw.com associated with source document(s)

Type:

http://dbpedia.demo.openlinksw.com/c/6w3ciSaiag

Arthur Wesley Nienhuis (August 9, 1941 – February 3, 2021) was an American physician who served as fourth director and CEO of St. Jude Children's Research Hospital from 1993 to 2004. Prior to joining St. Jude, Nienhuis was chief of the Clinical Hematology Branch and deputy clinical director at the National Institutes of Health's Heart, Lung and Blood Institute. His research interests and expertise in bone marrow transplant, gene therapy and genetic testing paved the way for many advances at St. Jude, including breakthroughs in sickle cell disease and other hematological disorders. Nienhuis also made significant achievements in the fields of cell therapy, HIV/AIDS research and inherited immunodeficiencies. Under his leadership, the hospital completed a $1 billion expansion, which included t

Attributes	Values
rdf:type	Thing foaf:Person person dul:NaturalPerson Eukaryote Person Human Animal yago:WikicatAmericanChiefExecutives yago:WikicatAmericanMedicalResearchers yago:WikicatAmericanPhysicians animal eukaryote medician scientist species schema:Person yago:WikicatLivingPeople Scientist yago:Administrator109770949 yago:Adult109605289 yago:CausalAgent100007347 yago:Doctor110020890 yago:Executive110069645 yago:Head110162991 yago:HealthProfessional110165109 yago:Leader109623038 yago:LivingThing100004258 yago:MedicalPractitioner110305802 yago:Object100002684 yago:Organism100004475 yago:Person100007846 yago:PhysicalEntity100001930 yago:Professional110480253 yago:ResearchWorker110523076 yago:YagoLegalActor yago:YagoLegalActorGeo yago:Scientist110560637 yago:Whole100003553
rdfs:label	Arthur W. Nienhuis (en)
rdfs:comment	Arthur Wesley Nienhuis (August 9, 1941 – February 3, 2021) was an American physician who served as fourth director and CEO of St. Jude Children's Research Hospital from 1993 to 2004. Prior to joining St. Jude, Nienhuis was chief of the Clinical Hematology Branch and deputy clinical director at the National Institutes of Health's Heart, Lung and Blood Institute. His research interests and expertise in bone marrow transplant, gene therapy and genetic testing paved the way for many advances at St. Jude, including breakthroughs in sickle cell disease and other hematological disorders. Nienhuis also made significant achievements in the fields of cell therapy, HIV/AIDS research and inherited immunodeficiencies. Under his leadership, the hospital completed a $1 billion expansion, which included t (en)
foaf:name	Arthur W. Nienhuis (en)
name	Arthur W. Nienhuis (en)
foaf:depiction
death date	2021-02-03 (xsd:date)
birth date	1941-08-09 (xsd:date)
dcterms:subject	2021 deaths 1941 births American health care chief executives American medical researchers Members of the National Academy of Medicine Members of the United States National Academy of Sciences American hematologists David Geffen School of Medicine at UCLA alumni American nonprofit chief executives Presidents of the American Society of Hematology
Wikipage page ID	22177657 (xsd:integer)
Wikipage revision ID	1099431919 (xsd:integer)
Link from a Wikipage to another Wikipage	2021 deaths Bill Clinton David Geffen School of Medicine at UCLA 1941 births Gene therapy Genetic testing American health care chief executives American medical researchers Members of the National Academy of Medicine Members of the United States National Academy of Sciences CEO American hematologists American Society of Hematology Hematology David Geffen School of Medicine at UCLA alumni American nonprofit chief executives Presidents of the American Society of Hematology St. Jude Children's Research Hospital Bone marrow transplant
sameAs	Arthur W. Nienhuis Arthur W. Nienhuis Arthur W. Nienhuis Arthur W. Nienhuis Arthur W. Nienhuis
specialism	Hematology
work institutions	University of Tennessee, St. Jude Children's Research Hospital (en)
dbp:wikiPageUsesTemplate	dbt:Birth_date dbt:Reflist dbt:Short_description dbt:Use_mdy_dates dbt:Death_date_and_age dbt:Infobox_medical_person
thumbnail	wiki-commons:Special:FilePath/Stjude_nienhuis_arthur.jpg?width=300
birth date	1941-08-09 (xsd:date)
death date	2021-02-03 (xsd:date)
image size	180 (xsd:integer)
known for	CEO of St. Jude Children's Research Hospital from 1993 to 2004. (en)
profession	Doctor (en)
has abstract	Arthur Wesley Nienhuis (August 9, 1941 – February 3, 2021) was an American physician who served as fourth director and CEO of St. Jude Children's Research Hospital from 1993 to 2004. Prior to joining St. Jude, Nienhuis was chief of the Clinical Hematology Branch and deputy clinical director at the National Institutes of Health's Heart, Lung and Blood Institute. His research interests and expertise in bone marrow transplant, gene therapy and genetic testing paved the way for many advances at St. Jude, including breakthroughs in sickle cell disease and other hematological disorders. Nienhuis also made significant achievements in the fields of cell therapy, HIV/AIDS research and inherited immunodeficiencies. Under his leadership, the hospital completed a $1 billion expansion, which included the addition of a Children's GMP, LLC facility. Additionally, Nienhuis oversaw the creation of the Departments of Developmental Neurobiology and Structural Biology. Nienhuis received numerous awards, including being named by former president Bill Clinton to the National Cancer Advisory Board in 1998. That same year, he was awarded the Stratton Medal by the American Society of Hematology, one of the society's highest honors for an outstanding body of work in hematology. Additionally, Nienhuis was inducted into the Institute of Medicine of the National Academy of Sciences in 2002. After completing his tenure at St. Jude Children's Research Hospital, Nienhuis returned to the laboratory, where he continued with his research which included the development of gene transfer for the treatment of hemophilia. He went to emeritus faculty status in 2016. (en)
prizes	Stratton Medal (en)
research field	Gene therapy Bone marrow transplant

Faceted Search & Find service v1.17_git147 as of Sep 06 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 08.03.3332 as of Dec 5 2024, on Linux (x86_64-generic-linux-glibc212), Single-Server Edition (378 GB total memory, 51 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software